
European Commission authorizes fifth vaccine against COVID-19
The European Commission on Monday granted conditional marketing authorization for Nuvaxovid, the fifth COVID-19 vaccine authorized in the European Union (EU). The authorization of the vaccine, developed by Novavax, followed a scientific recommendation based on [Read More]